The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.

But there’s hope.

We believe there is a better way to address serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.

Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solutions (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia and ventricular tachycardia.

The Abbott 3D Mapping System received FDA Clearance in 2013 band is now in routine use at several leading medical centers throughout the United States.

In the News

Letter from the Editor in Chief, Innovations in Cardiac Rhythm Management
If this technology pans out for atrial fibrillation it could truly represent the holy grail of atrial fibrillation ablation. As we have used this technology
Heart to Heart: Cardiologists collaborate to study atrial fibrillation
For many years, doctors thought atrial fibrillation was caused by many electrical circuits misfiring all over the upper atrial chambers of the heart. Ablation has
Top cardiovascular technology trends of 2012, The Advisory Board Company
FIRM ablation on the horizon… This procedure refers to the process of targeting physiologic factors, known as rotors or focal impulses, to uncover AF€™s cause.
Focal Impulse and Rotor Modulation (FIRM) for Paroxysmal and Persistent Atrial Fibrillation, EPLabDigest
€œIndependent laboratories now show that stable rotors and focal sources sustain paroxysmal as well as persistent AF. Elimination of all patient-specific sources by FIRM can
AHA 2012 Wrap Up, Matthew J Dodds, Citigroup
The mapping concept of picking up electrical rotors and performing site specific ablation vs. broad-based tissue scarring so its RhythmView system has the potential to
FIRM-guided ablation: The next big thing for AF?
FIRM ablation refers to the process of targeting physiologic factors (namely, rotors and focal impulses) to uncover the root cause of AF, whereas traditional approaches
Device Companies Follow New Map to Atrial Fibrillation
€œGiven what we don€™t know about the causes and sources of atrial fibrillation, there are those who think that developing new ablation catheters is almost
Technology Creates 3-D Maps of Heart€™s Electrical Activity, San Diego Business Journal
Abbott Medical Inc.€™’s RhythmView technology, which is a GPS of the heart€™s electrical activity, is steadily gaining attention among U.S. physicians who diagnose and treat
HRS Wrap-Up: Physician Perspectives on Leads, New Technology and Procedures. Rick Wise, Leerink Swann
Privately held Abbott again caused quite a stir at HRS with its theory of rotors perpetuating AF, the “FIRM” procedure, and encouraging early experiences. Every
HRS 2012 Wrap UP, Matthew J Dodds, Citigroup
€œPrivately-held Topera’€™s electrical rotor mapping technology garners EP commentary a bit like the reaction to the concept of Tesla cars of a few years ago,
<< 1 | 2 | 3 | 4 | >>